Cited by 58Neurotransmitter Receptor Influence on BehaviorGenetic Associations and EpidemiologyPharmacogenetics and Drug Metabolism

Genotype and ancestry modulate brain's DAT availability in healthy humans

Open access
Shumay, Elena, Chen, John, Fowler, Joanna S., Volkow, Nora D.·2011·PLoS ONE

Abstract

The dopamine transporter (DAT) is a principal regulator of dopaminergic neurotransmission and its gene (the SLC6A3) is a strong biological candidate gene for various behavioral- and neurological disorders. Intense investigation of the link between the SLC6A3 polymorphisms and behavioral phenotypes yielded inconsistent and even contradictory results. Reliance on objective brain phenotype measures, for example, those afforded by brain imaging, might critically improve detection of DAT genotype-phenotype association. Here, we tested the relationship between the DAT brain availability and the SLC6A3 genotypes using an aggregate sample of 95 healthy participants of several imaging studies. These studies employed positron emission tomography (PET) with [¹¹C]cocaine wherein the DAT availability was estimated as Bmax/Kd; while the genotype values were obtained on two repeat polymorphisms--3-UTR- and intron 8--VNTRs. The main findings are the following: 1) both polymorphisms analyzed as single genetic markers and in combination (haplotype) modulate DAT density in midbrain; 2) ethnic background and age influence the strength of these associations; and 3) age-related changes in DAT availability differ in the 3-UTR and intron 8--genotype groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0022754

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These polymorphisms have been separately linked with DAT density in the striatum.

    “These polymorphisms have been separately linked with DAT density in the striatum, while recent evidence suggests that their joint consideration in haplotypes may provide more information than can be inferred from the analyses of single genetic markers.25”
  • The function of the dopaminergic mechanism and the role of polymorphic variation in dopamine genes vary with age, making extrapolation from adult studies difficult.

    “Yet the function of the dopaminergic mechanism and the role of polymorphic variation in dopamine genes vary with age,24,25 making extrapolation from adult studies difficult.”
  • Recent evidence suggests that joint consideration of these polymorphisms in haplotypes may provide more information than analyses of single genetic markers.

    “These polymorphisms have been separately linked with DAT density in the striatum, while recent evidence suggests that their joint consideration in haplotypes may provide more information than can be inferred from the analyses of single genetic markers.25”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [60]Júlia PG Guilherme VP Cristian Z Angélica SO Tatiana R 2008 A common haplotype at the dopamine transporter gene 5prime region is associated with attention-deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B 1568 1575 18802919

Cited by

Sorted by citations

Authors
Shumay, E., Chen, J., Fowler, J. S., & Volkow, N. D.
Affiliations
  • Brookhaven National Laboratory (US)
  • Stony Brook University (US)
  • National Institutes of Health (US)
Corresponding author
Shumay, Elena
Venue
PLoS ONE
Published
2011-08-03
Volume
6
Issue
8
Pages
e22754
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2020233785
Cited by
58
References
70
Citations by year
2024: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 2 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 9 · 2012: 7
FWCI
3.31
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • U.S. Department of Energy
  • National Institutes of Health
  • National Institute on Drug Abuse (KO1 DA025280, K01DA025280, KO1 DA025280-01A1, K05DA020001, K05 DA20001)
  • Biological and Environmental Research
  • Brookhaven National Laboratory
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
dopamine transporter, dopamine transporter availability, genotype-phenotype correlation, haplotypes, ethnic ancestry, age-related changes, midbrain, dopamine signaling
MeSH terms
Adult, Brain, Female, Genotype, Haplotypes, Humans, Male, Middle Aged, Polymorphism, Genetic, Positron-Emission Tomography, Dopamine Plasma Membrane Transport Proteins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review